TY - JOUR
T1 - Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss
T2 - a population-based case-control study
AU - Lassen, Jonathan
AU - Jensen, Anne Kirstine
AU - Bager, Peter
AU - Pedersen, Carsten
AU - Panum, Inge
AU - Nørgaard-Pedersen, Bent
AU - Aaby, Peter
AU - Wohlfahrt, Jan
AU - Melbye, Mads
PY - 2012/10/9
Y1 - 2012/10/9
N2 - Because parvovirus B19 infection during pregnancy has been associated with increased risk of fetal loss in small or selected study populations, the authors evaluated the risk in a population-based study. A nested case-control study was conducted by using a population-based screening for syphilis in 3 regions in Denmark from 1992 to 1994. Cases of women with fetal loss were identified in the National Patient Register (n = 2,918), and control women with live-born children were identified in the Medical Birth Register (n = 8,429) by matching on age and sampling week. First-trimester serum samples were tested for parvovirus B19 immunoglobulin M positivity. Parvovirus B19 immunoglobulin M positivity was associated with a 71% increased risk of fetal loss (odds ratio = 1.71, 95% confidence interval: 1.02, 2.86). Adjustment for number of children or stratifying for gestational age at loss did not change the risk estimate. Assuming causality, only 0.1% of fetal losses were attributable to parvovirus B19 positivity, a proportion which could increase to approximately 1% during epidemic periods. In conclusion, acute parvovirus B19 infection during the first trimester of pregnancy was associated with an increased risk of fetal loss. However, the impact on the overall burden of fetal losses appeared small even during epidemics.
AB - Because parvovirus B19 infection during pregnancy has been associated with increased risk of fetal loss in small or selected study populations, the authors evaluated the risk in a population-based study. A nested case-control study was conducted by using a population-based screening for syphilis in 3 regions in Denmark from 1992 to 1994. Cases of women with fetal loss were identified in the National Patient Register (n = 2,918), and control women with live-born children were identified in the Medical Birth Register (n = 8,429) by matching on age and sampling week. First-trimester serum samples were tested for parvovirus B19 immunoglobulin M positivity. Parvovirus B19 immunoglobulin M positivity was associated with a 71% increased risk of fetal loss (odds ratio = 1.71, 95% confidence interval: 1.02, 2.86). Adjustment for number of children or stratifying for gestational age at loss did not change the risk estimate. Assuming causality, only 0.1% of fetal losses were attributable to parvovirus B19 positivity, a proportion which could increase to approximately 1% during epidemic periods. In conclusion, acute parvovirus B19 infection during the first trimester of pregnancy was associated with an increased risk of fetal loss. However, the impact on the overall burden of fetal losses appeared small even during epidemics.
KW - Case-Control Studies
KW - Denmark
KW - Female
KW - Fetal Death
KW - Gestational Age
KW - Humans
KW - Immunoglobulin M
KW - Parvoviridae Infections
KW - Parvovirus B19, Human
KW - Pregnancy
KW - Pregnancy Complications, Infectious
KW - Pregnancy Trimester, First
KW - Risk Factors
U2 - 10.1093/aje/kws177
DO - 10.1093/aje/kws177
M3 - Journal article
C2 - 23051601
SN - 0002-9262
VL - 176
SP - 803
EP - 807
JO - American Journal of Epidemiology
JF - American Journal of Epidemiology
IS - 9
ER -